人横纹肌肉瘤细胞RD
BLUEFBIO™ Product Sheet
细胞名称 |
人横纹肌肉瘤细胞RD |
|
|
货物编码 |
BFN60807544 |
||
产品规格 |
T25培养瓶x1 |
1.5ml冻存管x2 |
|
细胞数量 |
1x10^6 |
1x10^6 |
|
保存温度 |
37℃ |
-198℃ |
|
运输方式 |
常温保温运输 |
干冰运输 |
|
安全等级 |
1 |
||
用途限制 |
仅供科研 1类 |
培养体系 |
90%DMEM+10%FBS+1%双抗 |
||
培养温度 |
37℃ |
二氧化碳浓度 |
5% |
简介 |
人横纹肌肉瘤细胞RD取自7岁女性供体。 |
||
注释 |
Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel. Doubling time: 23 hours (PubMed=20922763). Microsatellite instability: Stable (MSS) (Sanger). Omics: Cell surface proteome. Omics: Deep exome analysis. Omics: Deep quantitative proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Exosome proteome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. |
||
基因突变 |
Homozygous for NRAS p.Gln61His (c.183A>T) (PubMed=3158613; PubMed=12068308; PubMed=22142829; ATCC). Homozygous for TP53 p.Arg248Trp (c.742C>T) (PubMed=2216456; ATCC). |
||
HLA信息 |
/ |
||
STR信息 |
Amelogenin X CSF1PO 10,11 D2S1338 17,23 D3S1358 15,17 D5S818 11 D7S820 8,12 D8S1179 11,15 D13S317 13 D16S539 10,11 D18S51 13,18 D19S433 11,14 D21S11 28,29 FGA 20,21 Penta D 11,13 Penta E 12 TH01 9.3 TPOX 9 vWA 18
|
||
参考文献 |
PubMed=31068700; DOI=10.1038/s41586-019-1186-3 Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569:503-508(2019)
PubMed=31448612; DOI=10.1021/acs.jproteome.9b00157 Rammal G., Fahs A., Kobeissy F., Mechref Y., Zhao J., Zhu R., Diab-Assaf M., Saab R., Ghayad S.E. Proteomic profiling of rhabdomyosarcoma-derived exosomes yield insights into their functional role in paracrine signaling. J. Proteome Res. 18:3567-3579(2019)
PubMed=31978347; DOI=10.1016/j.cell.2019.12.023 Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III, Kalocsay M., Jane-Valbuena J., Gelfand E., Schweppe D.K., Jedrychowski M., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P. Quantitative proteomics of the Cancer Cell Line Encyclopedia. Cell 180:387-402(2020) |